Slingshot members are tracking this event:
JUVÉDERM VOLBELLA XC Approved By U.S. FDA For Use In Lips And Perioral Rhytids
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|AGN||Community voting in process|
Slingshot Insights Explained
Jun 01, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Juvederm Volbella Xc, Perioral Rhytids, Perioral Lines